Frank R. Hunt
Currently, President, bioStrategies, Inc., a new enterprise development firm specializing in the early-stage, strategic development of university-based technologies and associated commercial opportunities within the life sciences industry. Examples of companies founded and managed include ErythroGen, Inc. (artificial blood substitute and gene therapy) and Sláinte Bioceuticals, Inc. (chemotherapeutic agents), serving as President/CEO of both. Prior work experience includes a range of senior roles in executive/general management within firms such as Murex Corporation/International Murex, Baxter Healthcare and TM Analytic. Educational background includes a Bachelor of Science Degree from Valparaiso University, Master of Science Degree in Virology and Immunology from Georgia State University, and a Master of Business Administration in Marketing from Georgia State University, Executive Program.